Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Ras Gene02:38

The Ras Gene

7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.6K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
Lethal Alleles02:41

Lethal Alleles

18.5K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
18.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

2.5K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II.

Science translational medicine·2026
Same author

0.33<i>g</i> mitigates muscle atrophy while 0.67<i>g</i> preserves muscle function and myofiber type composition in mice during spaceflight.

Science advances·2026
Same author

BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL.

Blood·2026
Same author

Lipid metabolism transcriptomic signature of defective erythropoiesis in Diamond Blackfan anemia syndrome.

Blood advances·2026
Same author

Enhanced induction of fetal hemoglobin by the combination of decitabine with RN-1 in β-thalassemia/HbE erythroid progenitor cells.

Molecular medicine (Cambridge, Mass.)·2026
Same author

p27Kip1 regulates γ-globin production.

Blood·2025

Related Experiment Video

Updated: Feb 28, 2026

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

7.9K

GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis.

Saori Katayama1,2, Mikiko Suzuki3, Ayaka Yamaoka1

  • 1Department of Medical Biochemistry.

Blood
|June 21, 2017
PubMed
Summary

Chromosomal rearrangements causing EVI1 overexpression and GATA2 haploinsufficiency accelerate leukemia. This study shows both factors are crucial for leukemogenesis in a 3q21q26 mouse model.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.5K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.6K

Related Experiment Videos

Last Updated: Feb 28, 2026

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

7.9K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.5K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.6K

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Chromosomal rearrangements at 3q21 and 3q26 can lead to myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).
  • These rearrangements inappropriately activate the EVI1 gene by bringing it near a GATA2-distal hematopoietic enhancer (G2DHE).
  • This process also reduces GATA2 levels, as the enhancer is moved away from one GATA2 allele, causing GATA2 haploinsufficiency, a known risk factor for MDS and AML.

Purpose of the Study:

  • To investigate whether both EVI1 misexpression and GATA2 haploinsufficiency contribute to leukemogenesis.
  • To utilize a 3q21q26 mouse model that mimics EVI1 misexpression and GATA2 haploinsufficiency.

Main Methods:

  • A 3q21q26 mouse model was employed, featuring G2DHE-driven EVI1 misexpression coupled with a heterozygous germ line deletion of Gata2.
  • Leukemic cells (B220+ and/or Gr1+) in bone marrow were analyzed.
  • Competitive transplantation assays were performed to assess the impact of Gata2 heterozygous deletion on leukemia cell expansion.

Main Results:

  • The Gata2 heterozygous deletion accelerated EVI1-induced leukemic transformation, leading to earlier onset of leukemia.
  • Leukemia-initiating cells were identified within the B220+Gr1-c-Kit+ population, which also supplied Gr1+ leukemia cells.
  • Reduced Gata2 expression suppressed myeloid differentiation, induced proliferation, and promoted B-lymphoid characteristics in these cells.
  • Gata2 heterozygous deletion provided a selective advantage for EVI1-expressing leukemia cell expansion.

Conclusions:

  • Both inappropriate EVI1 stimulation and GATA2 haploinsufficiency are critical contributors to accelerated leukemogenesis.
  • These findings highlight the complex interplay between EVI1 and GATA2 in the development of MDS and AML.